A Phase 1, Open-label, Crossover Study to Determine the Intra-subject Variability of the Pharmacokinetics of Single Oral Capsule Dose of 20 mg Lomitapide in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 31 Jul 2014
Price : $35 *
At a glance
- Drugs Lomitapide (Primary)
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type I; Hyperlipoproteinaemia type II
- Focus Pharmacokinetics
- Sponsors Aegerion Pharmaceuticals
- 26 Mar 2014 Status changed from recruiting to completed European Clinical Trials Database.
- 26 Oct 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-002692-17).
- 08 Aug 2013 New trial record